Abstract
Synaptotagmin-1 (Syt1) is a presynaptic calcium sensor with two calcium binding domains, C2A and C2B, that triggers action potential-induced synchronous neurotransmitter release, while suppressing asynchronous and spontaneous release. We identified a de novo missense mutation (P401L) in the C2B domain in a patient with developmental delay and autistic symptoms. Expressing the orthologous mouse mutant (P400L) in cultured Syt1 null mutant neurons revealed a reduction in dendrite outgrowth with a proportional reduction in synapses. This was not observed in single Syt1PL-rescued neurons that received normal synaptic input when cultured in a control network. Patch-clamp recordings showed that spontaneous miniature release events per synapse were increased more than 500% in Syt1PL-rescued neurons, even beyond the increased rates in Syt1 KO neurons. Furthermore, action potential-induced asynchronous release was increased more than 100%, while synchronous release was unaffected. A similar shift to more asynchronous release was observed during train stimulations. These cellular phenotypes were also observed when Syt1PL was overexpressed in wild type neurons. Our findings show that Syt1PL desynchronizes neurotransmission by increasing the readily releasable pool for asynchronous release and reducing the suppression of spontaneous and asynchronous release. Neurons respond to this by shortening their dendrites, possibly to counteract the increased synaptic input. Syt1PL acts in a dominant-negative manner supporting a causative role for the mutation in the heterozygous patient. We propose that the substitution of a rigid proline to a more flexible leucine at the bottom of the C2B domain impairs clamping of release by interfering with Syt1’s primary interface with the SNARE complex. This is a novel cellular phenotype, distinct from what was previously found for other SYT1 disease variants, and points to a role for spontaneous and asynchronous release in SYT1-associated neurodevelopmental disorder.
Similar content being viewed by others
Introduction
Information processing in the brain depends on fast neurotransmission in synapses synchronized with presynaptic action potential (AP) activity. When an AP invades the presynaptic terminal, the rapid rise in calcium activates a set of specialized proteins which catalyze the synchronous fusion of neurotransmitter-filled synaptic vesicles [1]. This core fusion machinery comprises three soluble N-ethylmaleimide sensitive factor attachment protein receptors (SNAREs), that together provide the energy for fusion. It also includes key regulatory factors involved in the assembly and activation of the SNARE complex [2]. Mutations in genes encoding components of the core fusion machinery are increasingly found to underlie neurodevelopmental symptoms in patients [3,4,5] and define a new class of neurodevelopmental disorders referred to as SNAREopathies [6].
In recent years, several patients with neurodevelopmental symptoms of various severity have been described with de novo heterozygous missense mutations in the gene SYT1 [7, 8]. SYT1 encodes the calcium sensor Synaptotagmin-1 (Syt1) and belongs to the synaptotagmin family, a group of membrane associating proteins that contain two calcium binding C2 domains [9]. Among the 17 synaptotagmins, Syt1 is the predominant paralog for fast release in the forebrain [10], involved in vesicle docking, priming, fusion and endocytosis [9, 11,12,13,14,15]. Syt1’s primary role is to time-lock neurotransmitter release with millisecond precision to presynaptic APs, and to prevent asynchronous and spontaneous release between APs [16,17,18,19]. Before Ca2+-influx, the C2B domain binds the SNARE complex through the so-called primary interface [20, 21]. This prefusion Syt1-SNARE complex is thought to hinder membrane fusion, and to keep the release machinery in a state ready for fast release. During AP-induced Ca2+-influx, calcium binding to the Ca2+-binding loops of C2B induces their insertion into the membrane (disturbing the lipid bilayer), releasing the Syt1-SNARE interaction and enabling cooperation between Syt1 and the SNAREs in membrane fusion [20, 21]. Most of the pathogenic mutations in individuals with NDDs cluster at the Ca2+-binding sites in the C2B domain [7, 22], although mutations in the C2A domain were also reported [8]. These C2B mutants delayed release kinetics when overexpressed in wild type neurons, and failed to support evoked release when expressed in a Syt1 null background [7, 22, 23]. This has led to the idea that disruption of the Ca2+-dependent fusion role of Syt1 is the main molecular cause of Syt1 associated developmental disorders [23].
In this paper we describe an individual presenting with developmental delay and carrying a de novo heterozygous mutation c.1202 C > T, resulting in missense variant Pro401Leu. This substitution does not locate to a calcium-binding site, but flanks the C2B bottom face involved in membrane [12, 24] and SNARE [20, 25] binding. We show that the ability of Syt1 to suppress spontaneous and asynchronous release is impaired by this mutation, while its release triggering function is not affected. This novel phenotype is distinct from cellular phenotypes found for other SYT1 disease mutations and points towards a role for release synchronization in normal brain development.
Results
A novel de novo missense mutation in SYT1 in a patient with development delay and autistic symptoms
A 5.5 years old boy visited our multidisciplinary outpatient clinic because of unexplained tall stature, autistic features, and a mild developmental delay. He was born after an uneventful pregnancy at 41 weeks gestational age and his birth weight was 5 kg. He is the second child of non-consanguineous parents with unremarkable family history. His father was also tall as a child and his current height is 196 cm (+1.7 SD). Patient’s target height is +0.84 SD. Upon physical examination the boy had a height at +2.9 SD with normal weight and head circumference. He displayed mild hypermobility of the joints. No dysmorphic features were observed, except for widely spaced teeth and persistent fetal finger pads. He had one hyperpigmentation on his arm. At the age of 2 years old, his parents noted staring episodes. An EEG was performed but no abnormalities were found. His motor development was mildly delayed, and he started walking at the age of 22 months. His speech development was limited to a few words at the age of 36 months. At his first visit he spoke full sentences. He attended regular school, but experienced learning and behavioral problems (impaired concentration, limited interaction with his peers) and currently attends special needs education. At the age of 5 years, a pervasive developmental disorder not otherwise specified was diagnosed. His total intelligent quotient (IQ) was estimated 64–81 based on intelligence tests (the Dutch Wechsler Preschool and Primary Scale of Intelligence-Third edition (WPPSI-III-NL)). In particular, sensory-processing and information-processing difficulties were identified and the child psychiatrist confirmed a neurobiological developmental disorder. At the age of 10 years he is able to walk, run and cycle. On the Vineland Adaptive Behavior Scales-3 his adaptive behavior on communication and socialization domains was measured as moderate-to-low skill level and on the daily living skills domain his adaptive skills were on an adequate-to-high level. Brain imaging as not been performed.
Compared to other cases with missense mutations in SYT1 [7] or a deletion of SYT1 [26] the patient described here appears to be mildly affected. The majority of these previously described cases, aged 3–21 years, had absent speech, delayed motor development, movement disorders such as dystonia or stereotypies and infant hypotonia. Their growth was normal. The phenotype of the patient described here shows overlap with these cases (delayed motor and speech development, joint hypermobility, neurobiological developmental disorder), but is remarkably milder.
The patient showed normal endocrine functions. Genetic testing revealed a normal male karyotype (46,XY), a normal repeat length of the (CGG)n repeat of the FMR1-gene, and SNP array analysis (Affymetrix CytoScan® HD) showed a normal male array pattern. Whole exome sequencing of DNA isolated from blood samples of the patient and his parents (performed with an Illumina HiSeq 4000 instrument) demonstrated a heterozygous missense variant in SYT1 (NM_005639.2(SYT1):c.1202 C > T p.(Pro401Leu) (Chr12(GRCh37):g.79842837 C > T)). This variant was not present in his parents.
The Pro401 residue is evolutionary conserved among various vertebrate and invertebrate orthologs, as well as in the human paralog Synaptotagmin-2 (Fig. 1A). No variation was found at this position in more than 76 000 genomes from healthy individuals of diverse ancestries in the gnomAD database (v3.1.2; https://gnomad.broadinstitute.org), indicating that Pro401Leu is not a common variant [27, 28]. Pro401 is located at the bottom of the C2B domain (Fig. 1B), opposite to the top Ca2+ binding loops, where previously characterized [7, 22, 23] mutations are located. The mutated proline is positioned next to two arginine residues (R399, R400) that directly interact with SNAP25 to form the primary Syt1-SNARE interface (inset Fig. 1B) [20, 21, 29] important for evoked synchronous release and suppression of spontaneous release [21, 29,30,31]. Altogether, this suggests that Pro401 could be an important residue for the function of Syt1, and that substitution with a Leucine at this location could have a pathogenic effect.
Syt1PL inhibits dendritic maturation
To investigate the effect of the patient Syt1 mutation Pro401Leu on neuronal development and synaptic transmission, we used lentiviral expression vectors containing an F2A-linked GFP (Fig. S1B) to express murine Syt1 carrying the homologous mutation Pro400Leu (Fig. 1A) (Syt1P400L; hereafter referred to as Syt1PL) or wild type Syt1 (Syt1WT) in cultured autaptic hippocampal neurons from Syt1 knockout mice [32, 33]. Autaptic neurons or “autapses” are single neurons cultured on micro-islands that innervate their own dendritic tree (Fig. 1C), allowing the assessment of morphological and synaptic parameters of individual neurons in a standardized manner [34, 35]. Immunostaining revealed that expression of Syt1 and GFP were similar between Syt1WT and Syt1PL-rescued neurons, and at the same ratio (Fig. S1A, C). Furthermore, Syt1 showed a high degree of colocalization with the presynaptic marker VGLUT1 (Fig. 1D, Fig. S1D), which was the same for Syt1PL and Syt1WT (Fig. S1D). Together, this indicates that that protein stability and synaptic targeting are unaffected by the PL mutation.
To assess the impact of the PL mutation on neuronal morphology, dendrites and synapses were visualized using MAP2 staining and VGLUT1/Syt1 staining, respectively (Fig. 1D) and analyzed with the semi-automated image analysis tool SynD [36]. Expression of Syt1PL decreased total dendrite length per neuron by 30% (Fig. 1E), with a concomitant reduction in the number of VGLUT1+/Syt1+ synaptic puncta as compared to Syt1WT-rescued neurons (Fig. 1F), but had no effect on synapse density (Fig. 1G). The size of VGLUT1+/Syt1+ synaptic puncta was the same in Syt1PL- and Syt1WT-rescued neurons (Fig. 1H). Dendritic branching, as quantified by Sholl analysis, was also reduced (Fig. 1I). These results indicate that Syt1PL affects dendrite outgrowth or stability, but not synaptogenesis.
Syt1PL impairs suppression of asynchronous release
Syt1’s main function is to trigger neurotransmitter release in response to a presynaptic AP [37]. To examine the impact of the patient mutation on AP-triggered release, we measured evoked postsynaptic currents (EPSCs) in autaptic hippocampal Syt1 null neurons rescued with either Syt1PL or Syt1WT using whole-cell voltage-clamp. The amplitude of EPSCs was considerably reduced in Syt1PL-rescued neurons as compared to Syt1WT-rescued neurons (Fig. 2A, B). Paired-pulse stimulations showed that the release probability did not differ between the groups (Fig. S2A, B). Despite a reduced amplitude, the total amount of release, as measured by EPSC charge [38] did not differ (Fig. 2C). This suggested that the time course of release was slower and more prolonged in Syt1PL-rescued neurons. However, rise times, measured as the time from stimulation onset to the peak of the EPSC, were the same for Syt1PL and Syt1WT (Fig. 2D). In order to quantify the EPSC decay time courses we fitted the decay phase with bi-exponential fits (Fig. 2A). While the decay time constants for the fast and slow components (τfast and τslow) were indistinguishable (Fig. 2F), the relative amplitude of the slow component was considerably larger in EPSCs from Syt1PL neurons compared to Syt1WT (Fig. 2E; Fig. S2C, D). We calculated the amount of synchronous and asynchronous release during a single EPSC by: (1) adding the current integrals of the rise phase and the fast component of decay to obtain the total amount of synchronous release (Fig. S2E), and (2) integrating the EPSC’s slow decay component to obtain asynchronous release (Fig. S2F). Compared to Syt1WT, Syt1PL-rescued neurons displayed a two-fold increase in the contribution of asynchronous release to the total amount of release per EPSC (Fig. 2G). Taken together, these data show that the PL mutation increases an asynchronous component in evoked release that is almost absent in Syt1WT -rescued neurons.
Syt1 also synchronizes neurotransmission by suppressing asynchronous release during prolonged stimulation [19]. To probe this function, we assessed synchronous and asynchronous release during 20 Hz stimulus trains (Fig. 2H). Rundown of synchronous EPSCs was unaffected in Syt1PL neurons (Fig. 2I). In line with the results for single EPSCs, Syt1PL and Sy1WT-rescued neurons transferred the same amount of charge during 20 Hz trains, but in Syt1PL, asynchronous release accounted for a larger fraction of the total release during the train (Fig. 2J). In addition, asynchronous release directly following the train (‘tail current’) was increased in Syt1PL neurons, as evidenced by a slower decay to baseline (Fig. 2H, K). These data show that the PL substitution also promotes asynchronous release during, and directly after, prolonged stimulation.
We employed 40 Hz stimulus trains (Fig. 2L) to estimate the total pool of readily releasable vesicles (RRP) and the vesicle recruitment rate [39]. The total charge transferred during 40 Hz stimulation did not differ between Syt1WT and Syt1PL-rescued neurons (Fig. S2G). Likewise, both RRP size and recruitment rate were similar in neurons expressing Syt1PL and Syt1WT (Fig. 2M). To corroborate our findings, we used hypertonic sucrose (500 mM) application as an independent approach to assess RRP size [35, 40] and again found no difference in RRP size (Fig. 2N, O), despite the reduced number of synapses in Syt1PL-expressing neurons (Fig. 1E). This suggests that Syt1PL-rescued neurons have more primed vesicles per synapse.
Syt1PL has a dominant-negative effect on dendrite length and suppression of asynchronous release
To investigate whether the Syt1PL variant affects neuronal morphology and synaptic function in the presence of WT Syt1, we overexpressed Syt1PL or Syt1WT in wild type (WT) neurons. All morphological and electrophysiological phenotypes found on the Syt1 KO background were confirmed, although with somewhat smaller effect sizes (see Table S1). Immunostaining for MAP2 and VGLUT1 (Fig. 3A) revealed that compared to overexpression of Syt1WT, overexpression of Syt1PL reduced dendrite length by 17% (Fig. 3B), with a proportional reduction in the number of synapses (Fig. 3C). Dendritic branching was likewise reduced (Fig. 3F), while synapse size and density were unaffected (Fig. 3D, E). EPSC amplitude, charge and time-to-peak did not differ (Fig. 4A–D). Again, time constants for the fast and slow components of the EPSC decay phase were not different (Fig. 4F), but the slow component contributed more to the total amplitude of Syt1PL EPSCs (Fig. 4E, Fig. S4A, B), which was associated with a 61% increase in the asynchronous fraction of release compared to Syt1WT (Fig. 4G, Fig. S4C, D). Similarly, we found an increase in the asynchronous fraction of release during 20 Hz trains, and a slower decay of the tail current after stimulation (Fig. 4H–K). Finally, the total charge released during a 40 Hz train, as well as the RRP and recruitment rate estimated from back-extrapolation, did not differ between the two groups (Fig. 4L–N). Altogether, these results indicate a dominant-negative effect of Syt1PL on dendrite length and suppression of asynchronous release.
Syt1PL has a dominant-negative effect on the suppression of spontaneous miniature release events
Syt1 suppresses spontaneous vesicle fusion, preventing premature release from the RRP [16, 41, 42]. Given that the Syt1PL failed to effectively suppress asynchronous release, we next examined Syt1PL’s ability to suppress spontaneous miniature release. Indeed, analysis of miniature EPSC (mEPSC) rates revealed a 4-fold higher rate in Syt1 null neurons rescued with Syt1PL as compared those rescued with Syt1WT (Fig. 5A, B). In addition, mEPSC amplitudes were increased in Syt1PL neurons (Fig. 5B), likely due to spurious summation of independent spontaneous events at these high release rates [43, 44]. To confirm this supposition and exclude the presence of any postsynaptic effect, we repeated the experiment in younger neurons (DIV10) where mEPSC rates are still low, and found that mEPSC amplitudes were unaffected (Fig. S5), arguing against the presence of any postsynaptic effect of Syt1PL. When measured in mass culture in the presence of TTX (1 μM), a similar increase in mEPSC frequency was observed (Fig. 5C, D), confirming that Syt1PL impairs the suppression of spontaneous miniature release and that the phenotype is not specific to autaptic cultures. Furthermore, overexpression of Syt1PL on a WT background yielded a similar 3-fold increase in mEPSC release rates compared to Syt1WT overexpression (Fig. 5E, F), with no differences in mEPSC amplitude (Fig. 5F). Together, these data suggest that Syt1PL has a dominant-negative effect on the suppression of spontaneous miniature release.
A previous study showed that substituting the arginine residues 398 and 399 to glutamine (R398,399Q) impaired the release clamping function of Syt1 and increased the frequency of spontaneous (mEPSC) release beyond KO levels [45]. To investigate whether the P400L mutation, located immediately next to these residues, has a similar effect on spontaneous release, we compared mEPSC rates in Syt1 null neurons expressing either GFP only or Syt1PL (Fig. 5G). Syt1 null neurons rescued with Syt1PL exhibited a 3.5-fold increase in mEPSC frequency compared to those that only expressed GFP (Fig. 5H), with again a small effect on mEPSC amplitude (Fig. 5H). This suggests that Syt1PL mutant increases spontaneous release rates beyond KO levels, probably by a mechanism similar to the Syt1 R398,399Q mutant.
Increased spontaneous synaptic activity leads to shorter dendrites in Syt1PL expressing neurons
The marked increase in spontaneous release rates caused by Syt1PL is hard to reconcile with the reduction in total synapse number caused by this mutation. This prompted us to wonder whether the morphological effects are caused by a compensatory mechanism to normalize spontaneous release rates, or vice versa. To address this question, we analyzed the morphology of Syt1 null/Syt1 knockdown (KD) neurons rescued with either Syt1PL or Syt1WT in the presence and absence of tetanus neurotoxin (TeNT), which silences all synaptic vesicle release by cleaving the essential SNARE VAMP2 [46]. The difference in dendrite length and synapse number observed between Syt1PL or Syt1WT expressing neurons was abolished in the presence of TeNT, while synaptic density was unchanged for all conditions (Fig. 6A–D). This suggests that the morphological phenotype is driven by synaptic activity, rather than a cell-autonomous effect. Interestingly, post-hoc analysis indicated that TeNT also reduced dendrite length (Fig. 6B), but not the number of synapses (Fig. 6C) in Syt1WT -rescued neurons, possibly due to the complete silencing of synapses, including AP-triggered neurotransmission.
To further investigate the role of spontaneous release on neuronal morphology, we tested whether receiving synaptic input from Syt1WT neurons could rescue the morphology of Syt1PL-expressing neurons. First, we assessed whether Syt1PL reduced dendrite length in mass cultures by tracing sparsely labeled single neurons in the network (Fig. 6E, F). Indeed, we found a reduced dendrite length in Syt1PL mass cultures (Fig. 6G, H), demonstrating that both the electrophysiological (Fig. 5C, D) and morphological phenotype are not restricted to autaptic cultures, but also present in mass cultures. Next, we co-cultured Syt1 null neurons rescued with either Syt1PL or Syt1WT at a ratio of ~1:8 with WT neurons from littermates, assuming that the rescued neurons would predominantly receive spontaneous input at normal frequencies from the surrounding WT neurons (Fig. 6I). In this preparation, the dendrite lengths of Syt1PL-rescued neurons were similar to those of Syt1WT-rescued neurons (Fig. 6J, K), and we found no difference in dendritic branching (Fig. 6L). These finding suggest that the observed reduction in dendrite length and dendritic branching exhibited by Syt1PL autaptic neurons is not cell-autonomous, but might rather depend on altered synaptic input.
Discussion
Syt1PL selectively impairs clamping of spontaneous and asynchronous release
In this study we identified a missense de novo mutation at a highly conserved location in Syt1 (P401L) in a patient with developmental delay and ASD symptoms. The PL mutant was equally well expressed and targeted to synapses as was WT Syt1. This suggests that the mutation causes disease by specific functional deficits, rather than protein instability/degradation or targeting deficits. Syt1 null neurons rescued with Syt1PL showed a 30% reduction in dendrite length with a concomitant reduction in synapses. The amount of asynchronous release per synapse during a single AP or train stimulation was increased, and spontaneous miniature release events were drastically increased in these neurons. The overall physiological and morphological phenotype observed with Syt1PL on Syt1 null background was also observed when this variant was expressed in WT neurons. Therefore, we conclude that this mutation causes disease due to a dominant-negative effect on Syt1 function.
While the increase in asynchronous and spontaneous release points to a presynaptic effect of Syt1PL, synaptotagmins and SNAREs also have a postsynaptic role in membrane insertion of AMPA receptors (AMPARs) [47, 48]. One possibility is that increased spontaneous AMPAR exocytosis is responsible for the increased mEPSC amplitude in Syt1PL-rescued neurons. An alternative explanation is the summation of simultaneous occurring mEPSC due to the high spontaneous release rates in this group. Indeed, in younger neurons with much lower mEPSC frequencies no effect on mEPSC amplitude was found, making the latter explanation more likely.
The effects on dendrite length and synapse number could arise either from a cell-autonomous postsynaptic effect of Syt1, or be induced by changes in synaptic input. The morphological differences between Syt1PL and Syt1WT neurons disappeared when synaptic activity was silenced by TeNT. In addition, dendrites of Syt1PL-rescued neurons developed normally when embedded in a mass culture of wild type cells, presumably receiving normal synaptic input from neighboring neurons, but not when receiving increased spontaneous input in Syt1PL mass culture. These findings suggest that the morphological changes are secondary to the electrophysiological phenotype. We speculate that this could be a homeostatic adaptation to the exceptionally high spontaneous miniature release rates and/or to increased AP-induced total release per synapse in these neurons [49], since no morphological defects were reported for Syt1 knockout (KO) neurons [34].
In contrast to previously described SYT1 disease variants (see below), the PL mutation did not affect the Ca2+-dependent fusion triggering function of Syt1. The fast component of AP-evoked EPSC’s showed normal kinetics, and normal short-term synaptic plasticity during train- or paired-pulse stimulation implied a normal vesicular release probability. Interestingly, despite the 30% reduction in synapses in Syt1PL-rescued neurons, we found a similar total RRP for the WT and PL group, suggesting an increased primed pool per synapse in Syt1PL-rescued neurons. Since both EPSC amplitudes and the total number of synapses were smaller in these neurons, these extra primed vesicles appear not to contribute to synchronous release, presumably docking more distantly from Ca2+ channels. Indeed, asynchronous release in response to a single AP or train stimulation was much more pronounced in Syt1PL-rescued synapses. In addition, we found that asynchronous release following train stimulation decayed slower back to baseline, further suggesting that clamping of asynchronous release is impaired by this mutation. In line with this notion, the mEPSC frequency was increased 4-fold in Syt1PL expressing neurons. Taking into account the reduced number of synapses, this translates to a 6-fold increase in spontaneous release from individual synapses. Altogether, our observations are best explained by a model in which Syt1PL increases the RRP for asynchronous release and has a selective impairment in the clamping of spontaneous and asynchronous release, while its release triggering function remains intact. In such a scenario, vesicles in Syt1PL and Syt1WT-rescued synapses will respond similarly to peak Ca2+ during single APs, and release with the same probability when located close to Ca2+ channels (Fig. 6M). However, reduced clamping in Syt1PL-rescued synapses renders vesicles more susceptible to low Ca2+ concentrations that occur locally immediately after the AP, or globally during train stimulation, hence increasing the probability for these vesicles to be released asynchronously.
Syt1PL has a unique cellular phenotype compared to other Syt1 disease mutations
Previously, physiological phenotypes of other de novo mutations in SYT1-associated with neurodevelopmental disorder [7, 22] have been studied. These mutations, mostly located in the Ca2+-binding and membrane penetrating loops of the C2B domain (D304G, D366E, and I368T) caused an almost complete loss of AP-induced synchronous release, while the ability to clamp spontaneous release varied between the genotypes [23]. The phenotype that we found for the current Syt1PL patient mutation, characterized by specific increases in spontaneous and asynchronous release without affecting synchronous release, is very dissimilar to those described for the C2B mutations. Spontaneous release has been proposed to play a role in guiding synapse maturation during development, synaptic scaling, homeostatic plasticity and excitability of neuronal networks [50, 51]. Furthermore, desynchronization of release could negatively impact the precise timing of neurotransmission, important for spike-timing dependent plasticity and information processing [52, 53]. As such, the mutation in the patient could potentially affect these aspects of brain function. We further show that dendritic growth was inhibited in the Syt1PL-rescued neurons. Abnormalities in dendritic growth have been proposed to be some of the major defects in ASD [54, 55], and might be causal to suggested differences in long-range versus short-range connections in ASD [56, 57]. While several cell models for neurodevelopmental disorders display either shortened [6, 58,59,60,61,62] or elongated [58, 63, 64] dendrites, dendritic abnormalities are absent in Syt1 KO neurons [34], and have not been associated with Syt1 disease mutations reported so far [7, 22, 23]. These findings demonstrate that mutations in the same synaptic gene can cause different cellular phenotypes, but largely overlapping clinical symptoms.
Perturbation of the SNARE-Syt1 primary interface impairs clamping function of Syt1
Here we report a point mutation in Syt1 that selectively impairs its clamping function and increases priming. Decoupling of the clamping and activation roles was shown before for the experimental Syt19PRO mutant, but with a more drastic modification of Syt1, involving the insertion of nine prolines in the linker between the C2A and C2B domain [14, 19]. The mutated proline P401 described in the current study is at a location that forms Syt1’s primary interface with the SNARE complex [21], and is directly adjacent to two arginine residues (R399, R400 in human Syt1; R398, R399 in mouse Syt1) (Fig. 6N). These arginines protrude from the bottom of the C2B domain to interact with SNAREs at rest, most likely to prevent full zippering, thereby preventing premature neurotransmitter release [20]. Previous studies showed that mutating the positively charged arginines to neutral glutamines (Syt1RQ) impaired the release clamping function, and increased spontaneous release rates beyond Syt1 KO levels [24, 45], similar to the effects of the PL mutation in the current study. These exceptionally high spontaneous release rates have been attributed to the C2A domain, still present in the Syt1RQ- (and Syt1PL-) expressing neurons, but not Syt1 KO neurons, which promotes spontaneous release in the absence of the release clamping action of the C2B domain [45]. However, contrary to what we found for the PL mutation, vesicle docking was strongly reduced, and synchronous release was completely abrogated in the RQ mutant [12, 24, 45]. We speculate that the specific loss of clamping in the PL mutant originates from rendering the primary interface less rigid through the substitution of a rigid proline with a more flexible leucine [65]. This could hamper the correct positioning of the arginines in the Syt1-SNARE interaction necessary for release clamping, while they are still available for membrane binding during docking [12] and evoked synchronous release [66].
Interestingly, the Syt1PL synaptic phenotype shows strong similarities to some of the recently described NDD-associated mutations located in the domain of SNAP25 that forms the primary interface with Syt1 [21, 50]. In particular, the SNAP25 variants L50S and V48F, both of which are located exactly opposite to Syt1 P401 in the crystal structure [21, 29] (Fig. 6N) strongly augmented spontaneous release with mild or no impairments in evoked release [50]. Hence, mutations in different genes that are part of the same complex can produce similar cellular phenotypes, whereas different mutations in the same gene can produce different cellular phenotypes (see discussion above). This shows the importance of in vitro phenotyping to uncover disease mechanisms in patients with different mutations in presynaptic genes.
Methods and materials
Ethical statement
Consent to describe the patient was obtained from the parents and apart from sequencing, no data was collected directly from the patient. Animals were housed and bred according to institutional and Dutch governmental guidelines, and all procedures are approved by the ethical committee of the Vrije Universiteit, Amsterdam, The Netherlands.
Laboratory animals and primary neuron cultures
Syt1−/− mice were generated by interbreeding heterozygous mice (C57BL/6 background). Hippocampal autaptic- and mass cultures were prepared as previously described [67]. In a few experiments Syt1 knockdown (KD) neurons were used, which is indicated in the text and figure legends. A detailed description of the culture methods and infection is given in the supplementary information.
Morphological analysis
Morphological parameters were obtained from confocal images of autaptic or mass cultures stained for dendritic (MAP2) and synaptic markers (Syt1 and VGLUT) and analyzed using the automated image analysis routine SynD [36]. A detailed description of the imaging and analysis methods is provided in the supplementary information.
Electrophysiology
Whole-cell voltage clamp recordings were performed in autaptic and mass cultures to measure evoked and spontaneous mEPSC release. Hypertonic sucrose application was used to estimate the readily releasable pool. All recordings were analyzed with in-house developed Matlab scripts. A detailed description of the patch-clamp experiments and analysis is provided in the supplementary information.
Statistical analysis
Statistical significance was determined using student’s- or Welch’s t tests, and Mann-Whitney U tests when normality could not be assumed. An overview of all statistical analyses and summary statistics (mean ± SD, or median ± MAD (median absolute deviation [68]) in case of deviations from normality) is provided in Table S1. All statistical tests were two-tailed, and p values below 0.05 were considered significant. A detailed description of the statistical methods is provided in the supplementary information.
References
Südhof TC. Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron. 2013;80:675–90.
Brunger AT, Choi UB, Lai Y, Leitz J, Zhou Q. Molecular mechanisms of fast neurotransmitter release. Annu Rev Biophys. 2018;47:469–97.
Cupertino RB, Kappel DB, Bandeira CE, Schuch JB, da Silva BS, Müller D, et al. SNARE complex in developmental psychiatry: neurotransmitter exocytosis and beyond. J Neural Transm. 2016;123:867–83.
Melland H, Carr EM, Gordon SL. Disorders of synaptic vesicle fusion machinery. J Neurochem. 2021;157:130–64.
Bonnycastle K, Davenport EC, Cousin MA. Presynaptic dysfunction in neurodevelopmental disorders: insights from the synaptic vesicle life cycle. J Neurochem. 2021;157:179–207.
Lammertse HCA, van Berkel AA, Iacomino M, Toonen RF, Striano P, Gambardella A, et al. Homozygous STXBP1 variant causes encephalopathy and gain-of-function in synaptic transmission. Brain. 2020;143:441–51.
Baker K, Gordon SL, Melland H, Bumbak F, Scott DJ, Jiang TJ, et al. SYT1-associated neurodevelopmental disorder: a case series. Brain. 2018;141:2576–91.
Melland H, Bumbak F, Kolesnik-Taylor A, Ng-Cordell E, John A, Constantinou P et al. Expanding the genotype and phenotype spectrum of SYT1-associated neurodevelopmental disorder. Genet Med. 2022; 24: 880–93
Wolfes AC, Dean C. The diversity of synaptotagmin isoforms. Curr Opin Neurobiol. 2020;63:198–209.
Südhof TC. A molecular machine for neurotransmitter release: synaptotagmin and beyond. Nat Med. 2013;19:1227–31.
de Wit H, Walter AM, Milosevic I, Gulyás-Kovács A, Riedel D, Sørensen JB, et al. Synaptotagmin-1 docks secretory vesicles to syntaxin-1/SNAP-25 acceptor complexes. Cell. 2009;138:935–46.
Chang S, Trimbuch T, Rosenmund C. Synaptotagmin-1 drives synchronous Ca2+-triggered fusion by C2B-domain-mediated synaptic-vesicle-membrane attachment. Nat Neurosci. 2018;21:33–40.
Chen Y, Hu S, Wu X, Xie Z, Wang Y, Wang B, et al. Synaptotagmin-1 is a bidirectional Ca2+ sensor for neuronal endocytosis. Proc Natl Acad Sci. 2022;119:e2111051119.
Bai H, Xue R, Bao H, Zhang L, Yethiraj A, Cui Q, et al. Different states of synaptotagmin regulate evoked versus spontaneous release. Nat Commun. 2016;7:1–9.
Yao J, Kwon SE, Gaffaney JD, Dunning FM, Chapman ER. Uncoupling the roles of synaptotagmin I during endo-and exocytosis of synaptic vesicles. Nat Neurosci. 2012;15:243–9.
Broadie K, Bellen HJ, DiAntonio A, Littleton JT, Schwarz TL. Absence of synaptotagmin disrupts excitation-secretion coupling during synaptic transmission. Proc Natl Acad Sci. 1994;91:10727–31.
Nishiki T-i, Augustine GJ. Dual roles of the C2B domain of synaptotagmin I in synchronizing Ca2+-dependent neurotransmitter release. J Neurosci. 2004;24:8542.
Xu J, Pang ZP, Shin O-H, Südhof TC. Synaptotagmin-1 functions as a Ca2+ sensor for spontaneous release. Nat Neurosci. 2009;12:759–66.
Huson V, van Boven MA, Stuefer A, Verhage M, Cornelisse LN. Synaptotagmin-1 enables frequency coding by suppressing asynchronous release in a temperature dependent manner. Sci Rep. 2019;9:1–19.
Voleti R, Jaczynska K, Rizo J. Ca2+-dependent release of synaptotagmin-1 from the SNARE complex on phosphatidylinositol 4,5-bisphosphate-containing membranes. eLife. 2020;9:e57154.
Zhou Q, Lai Y, Bacaj T, Zhao M, Lyubimov AY, Uervirojnangkoorn M, et al. Architecture of the synaptotagmin–SNARE machinery for neuronal exocytosis. Nature. 2015;525:62–7.
Baker K, Gordon SL, Grozeva D, van Kogelenberg M, Roberts NY, Pike M, et al. Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling. J Clin Investig. 2015;125:1670–8.
Bradberry MM, Courtney NA, Dominguez MJ, Lofquist SM, Knox AT, Sutton RB, et al. Molecular basis for synaptotagmin-1-associated neurodevelopmental disorder. Neuron. 2020;107:52–64.e57.
Xue M, Ma C, Craig TK, Rosenmund C, Rizo J.The Janus-faced nature of the C 2 B domain is fundamental for synaptotagmin-1 function. Nat Struct Mol Biol. 2008;15:1160
Chen Y, Wang Y-H, Zheng Y, Li M, Wang B, Wang Q-W, et al. Synaptotagmin-1 interacts with PI(4,5)P2 to initiate synaptic vesicle docking in hippocampal neurons. Cell Rep. 2021;34:108842.
Niclass T, Le Guyader G, Beneteau C, Joubert M, Pizzuti A, Giuffrida MG, et al. 12q21 deletion syndrome: Narrowing the critical region down to 1.6 Mb including SYT1 and PPP1R12A. Am J Med Genet Part A. 2020;182:2133–8.
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434–43.
Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 2024;625:92–100.
Zhou Q, Zhou P, Wang AL, Wu D, Zhao M, Südhof TC, et al. The primed SNARE–complexin–synaptotagmin complex for neuronal exocytosis. Nature. 2017;548:420–5.
Xue M, Ma C, Craig TK, Rosenmund C, Rizo J. The Janus-faced nature of the C2B domain is fundamental for synaptotagmin-1 function. Nat Struct Mol Biol. 2008;15:1160–8.
Schupp M, Malsam J, Ruiter M, Scheutzow A, Wierda KDB, Söllner TH, et al. Interactions between SNAP-25 and Synaptotagmin-1 are involved in vesicle priming, clamping spontaneous and stimulating evoked neurotransmission. J Neurosci. 2016;36:11865.
Bekkers JM, Stevens CF. Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. Proc Natl Acad Sci. 1991;88:7834–8.
Bekkers JM. Autaptic cultures: methods and applications. Front Synaptic Neurosci. 2020;12:18.
Huson V, Meijer M, Dekker R, ter Veer M, Ruiter M, van Weering JRT, et al. Post-tetanic potentiation lowers the energy barrier for synaptic vesicle fusion independently of Synaptotagmin-1. eLife. 2020;9:e55713.
Rosenmund C, Stevens CF. Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron. 1996;16:1197–1207.
Schmitz SK, Hjorth JJJ, Joemai RMS, Wijntjes R, Eijgenraam S, de Bruijn P, et al. Automated analysis of neuronal morphology, synapse number and synaptic recruitment. J Neurosci Methods. 2011;195:185–93.
Geppert M, Goda Y, Hammer RE, Li C, Rosahl TW, Stevens CF, et al. Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell. 1994;79:717–27.
Nishiki T-i, Augustine GJ. Synaptotagmin I synchronizes transmitter release in mouse hippocampal neurons. J Neurosci. 2004;24:6127–32.
Neher E. Merits and limitations of vesicle pool models in view of heterogeneous populations of synaptic vesicles. Neuron. 2015;87:1131–42.
Schotten S, Meijer M, Walter AM, Huson V, Mamer L, Kalogreades L, et al. Additive effects on the energy barrier for synaptic vesicle fusion cause supralinear effects on the vesicle fusion rate. Elife. 2015;4:e05531.
Chicka MC, Hui E, Liu H, Chapman ER. Synaptotagmin arrests the SNARE complex before triggering fast, efficient membrane fusion in response to Ca2+. Nat Struct Mol Biol. 2008;15:827–35.
Littleton JT, Stern M, Perin M, Bellen HJ. Calcium dependence of neurotransmitter release and rate of spontaneous vesicle fusions are altered in Drosophila synaptotagmin mutants. Proc Natl Acad Sci. 1994;91:10888–92.
Kombian SB, Hirasawa M, Mouginot D, Chen X, Pittman QJ. Short-term potentiation of miniature excitatory synaptic currents causes excitation of supraoptic neurons. J Neurophysiol. 2000;83:2542–53.
Hirasawa M, Pittman QJ. Nifedipine facilitates neurotransmitter release independently of calcium channels. Proc Natl Acad Sci. 2003;100:6139–44.
Courtney NA, Bao H, Briguglio JS, Chapman ER. Synaptotagmin 1 clamps synaptic vesicle fusion in mammalian neurons independent of complexin. Nat Commun. 2019;10:4076.
Hoogstraaten RI, van Keimpema L, Toonen RF, Verhage M. Tetanus insensitive VAMP2 differentially restores synaptic and dense core vesicle fusion in tetanus neurotoxin treated neurons. Sci Rep. 2020;10:10913.
Wu D, Bacaj T, Morishita W, Goswami D, Arendt KL, Xu W, et al. Postsynaptic synaptotagmins mediate AMPA receptor exocytosis during LTP. Nature. 2017;544:316–21.
Jurado S, Goswami D, Zhang Y, Molina AJM, Südhof TC, Malenka RC. LTP requires a unique postsynaptic SNARE fusion machinery. Neuron. 2013;77:542–58.
Okujeni S, Egert U. Self-organization of modular network architecture by activity-dependent neuronal migration and outgrowth. Elife. 2019;8:e47996.
Alten B, Zhou Q, Shin O-H, Esquivies L, Lin P-Y, White KI, et al. Role of aberrant spontaneous neurotransmission in SNAP25-associated encephalopathies. Neuron. 2021;109:59–72.e55.
Kavalali ET. The mechanisms and functions of spontaneous neurotransmitter release. Nat Rev Neurosci. 2015;16:5–16.
Dan Y, Poo M-m. Spike timing-dependent plasticity of neural circuits. Neuron. 2004;44:23–30.
Izhikevich EM, Desai NS, Walcott EC, Hoppensteadt FC. Bursts as a unit of neural information: selective communication via resonance. Trends Neurosci. 2003;26:161–7.
Gilbert J, Man H-Y. Fundamental elements in autism: from neurogenesis and neurite growth to synaptic plasticity. Front Cell Neurosci. 2017;11:359.
Weir R, Bauman M, Jacobs B, Schumann C. Protracted dendritic growth in the typically developing human amygdala and increased spine density in young ASD brains. J Comp Neurol. 2018;526:262–74.
Just MA, Keller TA, Malave VL, Kana RK, Varma S. Autism as a neural systems disorder: a theory of frontal-posterior underconnectivity. Neurosci Biobehav Rev. 2012;36:1292–313.
Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA, Webb SJ. Autism and abnormal development of brain connectivity. J Neurosci. 2004;24:9228–31.
Deshpande A, Yadav S, Dao DQ, Wu Z-Y, Hokanson KC, Cahill MK, et al. Cellular phenotypes in human iPSC-derived neurons from a genetic model of autism spectrum disorder. Cell Rep. 2017;21:2678–87.
Katrancha SM, Shaw JE, Zhao AY, Myers SA, Cocco AR, Jeng AT, et al. Trio haploinsufficiency causes neurodevelopmental disease-associated deficits. Cell Rep. 2019;26:2805–17.e2809.
Khatri N, Gilbert JP, Huo Y, Sharaflari R, Nee M, Qiao H, et al. The autism protein Ube3A/E6AP remodels neuronal dendritic arborization via caspase-dependent microtubule destabilization. J Neurosci. 2018;38:363.
Moore SM, Seidman JS, Ellegood J, Gao R, Savchenko A, Troutman TD, et al. Setd5 haploinsufficiency alters neuronal network connectivity and leads to autistic-like behaviors in mice. Transl Psychiatry. 2019;9:24.
Yi F, Danko T, Botelho SC, Patzke C, Pak C, Wernig M, et al. Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. Science. 2016;352:aaf2669.
Weston MC, Chen H, Swann JW. Loss of mTOR repressors Tsc1 or Pten has divergent effects on excitatory and inhibitory synaptic transmission in single hippocampal neuron cultures. Front Mol Neurosci. 2014;7:1.
Zaslavsky K, Zhang W-B, McCready FP, Rodrigues DC, Deneault E, Loo C, et al. SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons. Nat Neurosci. 2019;22:556–64.
George RA, Heringa J. An analysis of protein domain linkers: their classification and role in protein folding. Protein Eng Des Select. 2002;15:871–9.
Voleti R, Jaczynska K, Rizo J. Ca2+-dependent release of synaptotagmin-1 from the SNARE complex on phosphatidylinositol 4, 5-bisphosphate-containing membranes. Elife. 2020;9:e57154.
Brouwer M, Farzana F, Koopmans F, Chen N, Brunner JW, Oldani S, et al. SALM 1 controls synapse development by promoting F‐actin/PIP2‐dependent Neurexin clustering. EMBO J. 2019;38:e101289.
Leys C, Ley C, Klein O, Bernard P, Licata L. Detecting outliers: do not use standard deviation around the mean, use absolute deviation around the median. J Exp Soc Psychol. 2013;49:764–6.
Lyubimov AY, Uervirojnangkoorn M, Zeldin OB, Zhou Q, Zhao M, Brewster AS, et al. Advances in X-ray free electron laser (XFEL) diffraction data processing applied to the crystal structure of the synaptotagmin-1/SNARE complex. Elife. 2016;5:e18740.
Sayers EW, Bolton EE, Brister JR, Canese K, Chan J, Comeau DonaldC, et al. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2021;50:D20–6.
Consortium TU. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2020;49:D480–9.
Acknowledgements
We would like to thank the patient and his parents for their cooperation. The authors thank Robbert Zalm and Ingrid Saarloos for their help with cloning and virus production, Lisa Laan and Desiree Schut for preparation of glia feeder plates, Joke Wortel and Joost Hoetjes for breeding- and genotyping of mutant mice, and Vincent Huson for developing MATLAB routines for the analysis of electrophysiological data. This work was supported by three grants (ZonMW-TOP (91216064), ZonMW-PSIDER (10250022110003), NWO-Dutch Research Agenda (NWA) (1160.18.200)) from the Netherlands Organization for Scientific Research (NWO) to MV and LNC.
Author information
Authors and Affiliations
Contributions
LC and MvB designed the study. MvB and MM performed experiments and analyzed data. PZ contributed patient evaluation and supervised the collection of clinical data. MvB and LC prepared the manuscript with input from PZ. MV reviewed and edited the manuscript. LC and MV supervised the project.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
van Boven, M.A., Mestroni, M., Zwijnenburg, P.J.G. et al. A de novo missense mutation in synaptotagmin-1 associated with neurodevelopmental disorder desynchronizes neurotransmitter release. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02444-5
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41380-024-02444-5
- Springer Nature Limited
This article is cited by
-
Expanding the genetic and phenotypic spectrum of Baker–Gordon syndrome: a new de novo SYT1 variant
Journal of Genetics (2024)